ArticleScience advances2024

Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.

Saranya Santhosh Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.